Differential microRNA expression profile in the plasma of preeclampsia and normal pregnancies

Zhong,Yan; Zhu,Fufan; Ding,Yiling

doi:10.3892/etm.2019.7637

Differential microRNA expression profile in the plasma of preeclampsia and normal pregnancies

Authors:
- Yan Zhong
- Fufan Zhu
- Yiling Ding
View Affiliations

Affiliations: Department of Gynaecology and Obstetrics, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, P.R. China
Published online on: June 3, 2019 https://doi.org/10.3892/etm.2019.7637
Pages: 826-832

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Preeclampsia is a common disease in pregnant women that can only be diagnosed from 20 weeks after fertilization. Developing early diagnosis markers is urgent and would be helpful in selecting appropriate treatment strategies. The present study aimed to identify the differential expression profiles of microRNAs in the plasma between patients with preeclampsia and normal pregnancies using microarray methods. Using quantitative polymerase chain reaction (qPCR), the differentially expressed microRNAs (miRNAs or miRs) identified from the microarray analysis were validated. A total of 3 miRNAs, including hsa‑miR‑1304‑5p, hsa‑miR‑320a and hsa‑miR‑5002‑5p, were upregulated in the plasma of patients with preeclampsia pregnancies. Examination of the functions of these miRNAs demonstrated that they were involved in cell proliferation, indicating that preeclampsia affected this pathway. In addition, 26 downregulated miRNAs were identified by microarray methods. The functions of these miRNAs included immune regulation, vascular development, cancer pathology and pathology of other disease (tuberculosis, oligozoospermia, psoriasis and Alzheimer's disease). Using qPCR, the most differentially expressed miRNAs were confirmed to be hsa‑miR‑1304‑5p, hsa‑miR‑320a and hsa‑miR‑5002‑5p, which were upregulated, as well as hsa‑miR‑188‑3p, hsa‑miR‑211‑5p, hiv1‑miR‑TAR‑3p, hsa‑miR‑4432 and hsa‑miR‑4498 that were significantly downregulated in the plasma of preeclampsia patients. The present findings may be useful in the development of early diagnosis markers and treatment targets for preeclampsia.

View Figures

View References

1	Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA and McLaughlin MK: Preeclampsia: An endothelial cell disorder. Am J Obstet Gynecol. 161:1200–1204. 1989. View Article : Google Scholar : PubMed/NCBI
2	Norwitz ER, Hsu CD and Repke JT: Acute complications of preeclampsia. Clin Obstet Gynecol. 45:308–329. 2002. View Article : Google Scholar : PubMed/NCBI
3	Ray JG, Vermeulen MJ, Schull MJ and Redelmeier DA: Cardiovascular health after maternal placental syndromes (CHAMPS): Population-based retrospective cohort study. Lancet. 366:1797–1803. 2005. View Article : Google Scholar : PubMed/NCBI
4	Zhong Y, Tuuli M and Odibo AO: First-trimester assessment of placenta function and the prediction of preeclampsia and intrauterine growth restriction. Prenat Diagn. 30:293–308. 2010.PubMed/NCBI
5	Steegers EA, von Dadelszen P, Duvekot JJ and Pijnenborg R: Pre-eclampsia. Lancet. 376:631–644. 2010. View Article : Google Scholar : PubMed/NCBI
6	Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell. 116:281–297. 2004. View Article : Google Scholar : PubMed/NCBI
7	Bartel DP: MicroRNAs: Target recognition and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
8	Wienholds E and Plasterk RH: MicroRNA function in animal development. FEBS Lett. 579:5911–5922. 2005. View Article : Google Scholar : PubMed/NCBI
9	Chiu RW and Lo YD: Pregnancy-associated microRNAs in maternal plasma: A channel for fetal–maternal communication? Clin Chem. 56:1656–1657. 2010. View Article : Google Scholar : PubMed/NCBI
10	Zhang Y, Fei M, Xue G, Zhou Q, Jia Y, Li L, Xin H and Sun S: Elevated levels of hypoxia-inducible microRNA-210 in pre-eclampsia: New insights into molecular mechanisms for the disease. J Cell Mol Med. 16:249–259. 2012. View Article : Google Scholar : PubMed/NCBI
11	Kumar P, Luo Y, Tudela C, Alexander JM and Mendelson CR: The c-Myc-regulated microRNA-17~92 (miR-17~92) and miR-106a~363 clusters target hCYP19A1 and hGCM1 to inhibit human trophoblast differentiation. Mol Cell Biol. 33:1782–1796. 2013. View Article : Google Scholar : PubMed/NCBI
12	Chim SS, Shing TK, Hung EC, Leung TY, Lau TK, Chiu RW and Lo YM: Detection and characterization of placental microRNAs in maternal plasma. Clin Chem. 54:482–490. 2008. View Article : Google Scholar : PubMed/NCBI
13	Luo SS, Ishibashi O, Ishikawa G, Ishikawa T, Katayama A, Mishima T, Takizawa T, Shigihara T, Goto T, Izumi A, et al: Human villous trophoblasts express and secrete placenta-specific microRNAs into maternal circulation via exosomes. Biol Reprod. 81:717–729. 2009. View Article : Google Scholar : PubMed/NCBI
14	Gu Y, Sun J, Groome LJ and Wang Y: Differential miRNA expression profiles between the first and third trimester human placentas. Am J Physiol Endocrinol Metab. 304:E836–E843. 2013. View Article : Google Scholar : PubMed/NCBI
15	Zhu X, Li Y and Jiang F: Differential expression and its clinical significance of miRNA in placentas from women with preeclampsia and normal pregnancy. Modern Med Health. 1:3–4. 2011.(In Chinese).
16	Le Jie: Obstetrics and Gynecology. People's Medical Publishing House; Beijing: pp. 92–101. 2008
17	Di Lorenzo G, Ceccarello M, Cecotti V, Ronfani L, Monasta L, Vecchi Brumatti L, Montico M and D'Ottavio G: First trimester maternal serum PIGF, free β-hcg, PAPP-A, PP-13, uterine artery doppler and maternal history for the prediction of preeclampsia. Placenta. 33:495–501. 2012. View Article : Google Scholar : PubMed/NCBI
18	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T))method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
19	Sibai BM: Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol. 102:181–192. 2003. View Article : Google Scholar : PubMed/NCBI
20	Wagner LK: Diagnosis and management of preeclampsia. Am Fam Physician. 70:2317–2324. 2004.PubMed/NCBI
21	Jonsson Y, Rubèr M, Matthiesen L, Berg G, Nieminen K, Sharma S, Ernerudh J and Ekerfelt C: Cytokine mapping of sera from women with preeclampsia and normal pregnancies. J Reprod Immunol. 70:83–91. 2006. View Article : Google Scholar : PubMed/NCBI
22	Suarez B, Alves K, Senat MV, Fromageot J, Fischer C, Rosenberg P and Ville Y: Abdominal pain and preeclampsia: Sonographic findings in the maternal liver. J Ultrasound Med. 21:1077–1083. 2002. View Article : Google Scholar : PubMed/NCBI
23	Pabinger I, Grafenhofer H, Kaider A, Ilic A, Eichinger S, Quehenberger P, Husslein P, Mannhalter C and Lechnerk: Preeclampsia and fetal loss in women with a history of venous thromboembolism. Arterioscler Thromb Vasc Biol. 21:874–879. 2001. View Article : Google Scholar : PubMed/NCBI
24	Li CG, Pu MF, Li CZ, Gao M, Liu MX, Yu CZ, Yan H, Peng C, Zhao Y, Li Y, et al: microRNA-1304 suppresses human non-small cell lung cancer cell growth in vitro by targeting heme oxygenase-1. Acta Pharmacol Sin. 38:110–119. 2017. View Article : Google Scholar : PubMed/NCBI
25	Sun JY, Huang Y, Li JP, Zhang X, Wang L, Meng YL, Yan B, Bian YQ, Zhao J, Wang WZ, et al: MicroRNA-320a suppresses human colon cancer cell proliferation by directly targeting β-catenin. Biochem Biophys Res Commun. 420:787–792. 2012. View Article : Google Scholar : PubMed/NCBI
26	Berillo O, Regnier M and Ivashchenko A: Binding of intronic miRNAs to the mRNAs of host genes encoding intronic miRNAs and proteins that participate in tumourigenesis. Comput Biol Med. 43:1374–1381. 2013. View Article : Google Scholar : PubMed/NCBI
27	Wang A, Rana S and Karumanchi SA: Preeclampsia: The role of angiogenic factors in its pathogenesis. Physiology (Bethesda). 24:147–158. 2009.PubMed/NCBI
28	Li J, Ying H, Cai G, Guo Q and Chen L: Pre-eclampsia-associated reduction in placental growth factor impaired beta cell proliferation through PI3k signalling. Cell Physiol Biochem. 36:34–43. 2015. View Article : Google Scholar : PubMed/NCBI
29	Hewagama A, Gorelik G, Patel D, Liyanarachchi P, McCune WJ, Somers E, Gonzalez-Rivera T; Michigan Lupus Cohort, ; Strickland F and Richardson B: Overexpression of X-linked genes in T cells from women with lupus. J Autoimmun. 41:60–71. 2013. View Article : Google Scholar : PubMed/NCBI
30	Zhou Y, Sun L, Wang X, Zhou L, Li J, Liu M, Wang F, Peng J, Gui X, Zhao H, et al: Heroin use promotes HCV infection and dysregulates HCV-related circulating microRNAs. J Neuroimmune Pharmacol. 10:102–110. 2015. View Article : Google Scholar : PubMed/NCBI
31	Ouellet DL, Vigneault-Edwards J, Létourneau K, Gobeil LA, Plante I, Burnett JC, Rossi JJ and Provost P: Regulation of host gene expression by HIV-1 TAR microRNAs. Retrovirology. 10:862013. View Article : Google Scholar : PubMed/NCBI
32	Ghanbari M, Sedaghat S, de Looper HW, Hofman A, Erkeland SJ, Franco OH and Dehghan A: The association of common polymorphisms in miR-196a2 with waist to hip ratio and miR-1908 with serum lipid and glucose. Obesity (Silver Spring). 23:495–503. 2015. View Article : Google Scholar : PubMed/NCBI
33	Qiao-li Z, Jim L, Xin-yang S, Wei G, Lin Z, Hui-min F, Ai-fang Z, Wei N, Yun-hua D, Li-yi Z, et al: A preliminary analysis of association between plasma microRNA expression alteration and symptomatology improvement in major depressive disorder (MDD) patients before and after antidepressant treatment. Eur J Psychiatry. 28:252–264. 2014. View Article : Google Scholar
34	Fu Y, Yi Z, Wu X, Li J and Xu F: Circulating microRNAs in patients with active pulmonary tuberculosis. J Clin Microbiol. 49:4246–4251. 2011. View Article : Google Scholar : PubMed/NCBI
35	Xu M, Qin Y, Qu J, Lu C, Wang Y, Wu W, Song L, Wang S, Chen F, Shen H, et al: Evaluation of five candidate genes from GWAS for association with oligozoospermia in a Han Chinese population. PLoS One. 8:e803742013. View Article : Google Scholar : PubMed/NCBI
36	Guo S, Zhang W, Wei C, Wang L, Zhu G, Shi Q, Li S, Ge R, Li K, Gao L, et al: Serum and skin levels of miR-369-3p in patients with psoriasis and their correlation with disease severity. Eur J Dermatol. 23:608–613. 2013.PubMed/NCBI
37	Wang WX, Rajeev BW, Stromberg AJ, Ren N, Tang G, Huang Q, Rigoutsos I and Nelson PT: The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J Neurosci. 28:1213–1223. 2008. View Article : Google Scholar : PubMed/NCBI